235 related articles for article (PubMed ID: 19798624)
61. Bevacizumab (avastin) for the treatment of retinopathy of prematurity.
Beaulieu MJ
Neonatal Netw; 2012; 31(4):242-7. PubMed ID: 22763251
[No Abstract] [Full Text] [Related]
62. Rethinking STOP-ROP: is it worthwhile trying to modulate excessive VEGF levels in prethreshold ROP eyes by systemic intervention? A review of the role of oxygen, light adaptation state, and anemia in prethreshold ROP.
Gaynon MW
Retina; 2006 Sep; 26(7 Suppl):S18-23. PubMed ID: 16946672
[TBL] [Abstract][Full Text] [Related]
63. Outcomes of a protocol-based management for zone 1 retinopathy of prematurity: the Indian Twin Cities ROP Screening Program report number 2.
Jalali S; Kesarwani S; Hussain A
Am J Ophthalmol; 2011 Apr; 151(4):719-724.e2. PubMed ID: 21257156
[TBL] [Abstract][Full Text] [Related]
64. [DOG (German Ophthalmological Society): retinopathy of prematurity best possible treatment. Antibody therapy - only advisable in certain cases].
Voormann AJ
Kinderkrankenschwester; 2012 Jun; 31(6):237. PubMed ID: 22808670
[No Abstract] [Full Text] [Related]
65. [Retinopathy of prematurity--screening results].
Vătavu I; Nascutzy C; Ciomârtan T; Brezan F; Anca I; Stoicescu S
Oftalmologia; 2010; 54(1):110-7. PubMed ID: 20540379
[TBL] [Abstract][Full Text] [Related]
66. Retinopathy of prematurity in the 1990s.
Lee S
Neonatal Netw; 1999 Mar; 18(2):31-8. PubMed ID: 10362998
[TBL] [Abstract][Full Text] [Related]
67. Retinopathy of prematurity.
Hutcheson KA
Curr Opin Ophthalmol; 2003 Oct; 14(5):286-90. PubMed ID: 14502056
[TBL] [Abstract][Full Text] [Related]
68. Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.
dell'Omo R; Kulkarni A; Franks WA
Acta Ophthalmol; 2008 Sep; 86(6):698-700. PubMed ID: 18081905
[No Abstract] [Full Text] [Related]
69. Hot Topics in Retinopathy of Prematurity.
Tsui I; Chu A
Pediatr Ann; 2017 Nov; 46(11):e415-e422. PubMed ID: 29131921
[TBL] [Abstract][Full Text] [Related]
70. Retinopathy of prematurity: A refresher for obstetricians.
Oleszczuk AK; Zagorski Z; Stankiewicz A; Mankowska A; Rejdak R; Oleszczuk JJ
Int J Fertil Womens Med; 2006; 51(2):89-96. PubMed ID: 16881385
[TBL] [Abstract][Full Text] [Related]
71. Educational paper: Retinopathy of prematurity.
Casteels I; Cassiman C; Van Calster J; Allegaert K
Eur J Pediatr; 2012 Jun; 171(6):887-93. PubMed ID: 22052209
[TBL] [Abstract][Full Text] [Related]
72. Retinopathy of prematurity: diagnosis and management [continuing education credit].
Vander JF
J Ophthalmic Nurs Technol; 1994; 13(5):207-12; quiz 238-9. PubMed ID: 7983684
[TBL] [Abstract][Full Text] [Related]
73. Retinopathy of prematurity in Bangladeshi neonates.
Ahmed AS; Muslima H; Anwar KS; Khan NZ; Chowdhury MA; Saha SK; Darmstadt GL
J Trop Pediatr; 2008 Oct; 54(5):333-9. PubMed ID: 18503093
[TBL] [Abstract][Full Text] [Related]
74. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.
Lalwani GA; Berrocal AM; Murray TG; Buch M; Cardone S; Hess D; Johnson RA; Puliafito CA
Retina; 2008 Mar; 28(3 Suppl):S13-8. PubMed ID: 18317338
[TBL] [Abstract][Full Text] [Related]
75. Update on retinopathy of prematurity: treatment options and outcomes.
Salvin JH; Lehman SS; Jin J; Hendricks DH
Curr Opin Ophthalmol; 2010 Sep; 21(5):329-34. PubMed ID: 20634698
[TBL] [Abstract][Full Text] [Related]
76. Screening for retinopathy of prematurity in a regional neonatal intensive care unit.
Stannard KP; Mushin AS; Gamsu HR
Eye (Lond); 1989; 3 ( Pt 4)():371-8. PubMed ID: 2481596
[TBL] [Abstract][Full Text] [Related]
77. [Screening analysis of retinopathy of prematurity and treatment of threshold retinopathy of prematurity].
Huang ZN; Yin DM; Huang DR; Liang SX
Zhonghua Yan Ke Za Zhi; 2006 Jun; 42(6):496-500. PubMed ID: 16857127
[TBL] [Abstract][Full Text] [Related]
78. Retinopathy of prematurity in the time of bevacizumab: incorporating the BEAT-ROP results into clinical practice.
Moshfeghi DM; Berrocal AM
Ophthalmology; 2011 Jul; 118(7):1227-8. PubMed ID: 21724044
[No Abstract] [Full Text] [Related]
79. Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity.
Quiroz-Mercado H; Martinez-Castellanos MA; Hernandez-Rojas ML; Salazar-Teran N; Chan RV
Retina; 2008 Mar; 28(3 Suppl):S19-25. PubMed ID: 18317339
[TBL] [Abstract][Full Text] [Related]
80. A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity.
Sears JE; Pietz J; Sonnie C; Dolcini D; Hoppe G
Ophthalmology; 2009 Mar; 116(3):513-8. PubMed ID: 19157560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
